Lili Hu

774 total citations
14 papers, 267 citations indexed

About

Lili Hu is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Lili Hu has authored 14 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Lili Hu's work include HIV/AIDS drug development and treatment (4 papers), Hepatitis C virus research (3 papers) and Click Chemistry and Applications (2 papers). Lili Hu is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Hepatitis C virus research (3 papers) and Click Chemistry and Applications (2 papers). Lili Hu collaborates with scholars based in China, Belgium and United States. Lili Hu's co-authors include Abdellah Tahri, Katie Amssoms, Pierre Raboisson, Ding Ma, Sandrine Vendeville, Dominique Surleraux, Piet Wigerinck, Koen Vandyck, Guang Zhang and Geert Pille and has published in prestigious journals such as Journal of Medicinal Chemistry, Biomedicine & Pharmacotherapy and Journal of Cellular and Molecular Medicine.

In The Last Decade

Lili Hu

14 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lili Hu China 10 117 84 76 40 39 14 267
Steve S. Carroll United States 9 138 1.2× 131 1.6× 68 0.9× 38 0.9× 31 0.8× 12 288
Zhili Sun United States 7 163 1.4× 71 0.8× 162 2.1× 66 1.6× 39 1.0× 7 372
Carlo Boutton Belgium 7 102 0.9× 57 0.7× 69 0.9× 47 1.2× 70 1.8× 9 232
Umesh Hanumegowda United States 12 164 1.4× 48 0.6× 31 0.4× 36 0.9× 39 1.0× 22 394
Sammy Metobo United States 7 64 0.5× 74 0.9× 75 1.0× 23 0.6× 17 0.4× 12 170
Roopa Rai United States 11 119 1.0× 41 0.5× 74 1.0× 48 1.2× 76 1.9× 21 360
Uma S. Singh United States 12 107 0.9× 68 0.8× 127 1.7× 100 2.5× 45 1.2× 24 320
Xiaohe Guo China 12 223 1.9× 86 1.0× 90 1.2× 47 1.2× 16 0.4× 32 445
Steven R. Mathieu United States 6 85 0.7× 116 1.4× 72 0.9× 66 1.6× 88 2.3× 8 255
David C. McGowan Belgium 10 94 0.8× 39 0.5× 121 1.6× 52 1.3× 32 0.8× 11 276

Countries citing papers authored by Lili Hu

Since Specialization
Citations

This map shows the geographic impact of Lili Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Hu more than expected).

Fields of papers citing papers by Lili Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Hu. The network helps show where Lili Hu may publish in the future.

Co-authorship network of co-authors of Lili Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Hu. A scholar is included among the top collaborators of Lili Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Hu. Lili Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Carbajo, Rodrigo J., Edgar Jacoby, Yanting Yin, et al.. (2024). Structure–Activity Relationship of Oxacyclo- and Triazolo-Containing Respiratory Syncytial Virus Polymerase Inhibitors. ACS Medicinal Chemistry Letters. 15(9). 1549–1558. 2 indexed citations
2.
Hu, Lili, Weiwei Shi, Ding Ma, et al.. (2024). EGFR bypass activation mediates acquired resistance to regorafenib in hepatocellular carcinoma. Frontiers in Medicine. 11. 3 indexed citations
3.
Ji, Anlai, et al.. (2022). Myricetin Induces Apoptosis and Protective Autophagy through Endoplasmic Reticulum Stress in Hepatocellular Carcinoma. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 12 indexed citations
4.
Zhou, Yan, Jiannan Qiu, Siyuan Liu, et al.. (2022). CFDP1 promotes hepatocellular carcinoma progression through activating NEDD4/PTEN/PI3K/AKT signaling pathway. Cancer Medicine. 12(1). 425–444. 11 indexed citations
5.
Ma, Ding, Shuwen Liu, Lili Hu, et al.. (2021). Single‐cell RNA sequencing identify SDCBP in ACE2‐positive bronchial epithelial cells negatively correlates with COVID‐19 severity. Journal of Cellular and Molecular Medicine. 25(14). 7001–7012. 19 indexed citations
6.
Shi, Weiwei, Ding Ma, Yin Cao, et al.. (2021). SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway. Frontiers in Molecular Biosciences. 8. 598218–598218. 23 indexed citations
7.
8.
Yao, Jin, Lili Hu, Xiu‐Miao Li, et al.. (2018). Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance. Biomedicine & Pharmacotherapy. 111. 548–554. 19 indexed citations
9.
Hu, Lili, et al.. (2017). Effect of sodium aescinate treatment on PCOS rat model with insulin resistance. Bratislavské lekárske listy/Bratislava medical journal. 118(4). 223–227. 7 indexed citations
10.
Jonckers, Tim H. M., Koen Vandyck, Lili Hu, et al.. (2013). Nucleotide Prodrugs of 2′-Deoxy-2′-spirooxetane Ribonucleosides as Novel Inhibitors of the HCV NS5B Polymerase. Journal of Medicinal Chemistry. 57(5). 1836–1844. 33 indexed citations
11.
Tan, Jianjun, et al.. (2012). Perspectives on Developing Small Molecule Inhibitors Targeting HIV-1 Integrase. Mini-Reviews in Medicinal Chemistry. 12(9). 875–889. 5 indexed citations
12.
Vandyck, Koen, Maxwell D. Cummings, Origène Nyanguile, et al.. (2009). Structure-Based Design of a Benzodiazepine Scaffold Yields a Potent Allosteric Inhibitor of Hepatitis C NS5B RNA Polymerase. Journal of Medicinal Chemistry. 52(14). 4099–4102. 50 indexed citations
13.
Raboisson, Pierre, Tse‐I Lin, Herman de Kock, et al.. (2008). Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5095–5100. 18 indexed citations
14.
Dierynck, Inge, Katie Amssoms, Lili Hu, et al.. (2004). Design and Optimization of Tricyclic Phtalimide Analogues as Novel Inhibitors of HIV-1 Integrase. Journal of Medicinal Chemistry. 48(6). 1930–1940. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steve S. Carroll Breakdown of academic impact, for papers by Zhili Sun Breakdown of academic impact, for papers by Carlo Boutton Breakdown of academic impact, for papers by Umesh Hanumegowda Breakdown of academic impact, for papers by Sammy Metobo Breakdown of academic impact, for papers by Roopa Rai Breakdown of academic impact, for papers by Uma S. Singh Breakdown of academic impact, for papers by Xiaohe Guo Breakdown of academic impact, for papers by Steven R. Mathieu Breakdown of academic impact, for papers by David C. McGowan
Rankless by CCL
2026